Showing results (41-50 of 88) with videos related to
Sort By:
Pageof 9
European Heart Journal. Cardiovascular Pharmacotherapy|January 5, 2019
Adherence to dabigatran etexilate in atrial fibrillation patients intended to undergo electrical cardioversionWillemijn J Comuth, Moniek P M de Maat, Daan van de Kerkhof, et al.The American Journal of Cardiology|July 7, 2009
Timing, causes, and predictors of death after three years' follow-up in the Danish Multicenter Randomized Study of Fibrinolysis versus Primary Angioplasty in Acute Myocardial Infarction (DANAMI-2) trialMartin Busk, Michael Maeng, Steen D Kristensen, et al.Thrombosis and Haemostasis|July 5, 2022
Resumption of Antiplatelet Therapy after Major BleedingTobias Geisler, Sven Poli, Kurt Huber, et al.Scientific Reports|October 25, 2023
The angiotensin-converting enzyme I/D polymorphism does not impact training-induced adaptations in exercise capacity in patients with stable coronary artery diseaseTórur Sjúrðarson, Jacobina Kristiansen, Nikolai B Nordsborg, et al.The Journal of Thoracic and Cardiovascular Surgery|October 4, 2015
One-year clinical and angiographic results of hybrid coronary revascularizationIvy S Modrau, Niels R Holm, Michael Mæng, et al.Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|July 29, 2021
Coronary Flow Velocity Reserve and Myocardial Deformation Predict Long-Term Outcomes in Heart Transplant RecipientsKamilla P Bjerre, Tor S Clemmensen, Steen H Poulsen, et al.Thrombosis Research|February 24, 2018
Comprehensive characteristics of the anticoagulant activity of dabigatran in relation to its plasma concentrationWillemijn J Comuth, Linda Ø Henriksen, Daan van de Kerkhof, et al.Thrombosis Research|September 3, 2017
The SH2B3 and KCNK5 loci may be implicated in regulation of platelet count, volume, and maturityMorten K Christiansen, Sanne B Larsen, Mette Nyegaard, et al.American Heart Journal|May 17, 2005
The relation of renal function to ischemic and bleeding outcomes with 2 different glycoprotein IIb/IIIa inhibitors: the do Tirofiban and ReoPro Give Similar Efficacy Outcome (TARGET) trialPeter B Berger, Patricia J M Best, Eric J Topol, et al.Thrombosis Research|March 21, 2017
Effect of long-term remote ischaemic conditioning on platelet function and fibrinolysis in patients with chronic ischaemic heart failureKasper Pryds, Jacobina Kristiansen, Søs Neergaard-Petersen, et al.Pageof 9